Sarilumab by Regeneron Pharmaceuticals for Polyarticular Juvenile Idiopathic Arthritis (PJIA): Likelihood of Approval

Sarilumab is under clinical development by Regeneron Pharmaceuticals and currently in Pre-Registration for Polyarticular Juvenile Idiopathic Arthritis (PJIA).

Omega-3 rich oil can prevent damage to honey bee mitochondria caused by pesticides

New research suggests that the use of an omega-3 rich oil called “ahiflower oil” can prevent damage to honey bee mitochondria caused by neonicotinoid pesticides.

July 4, 2023

Peds Fellow Fired After Child Porn Charges; Jury Awards Doc $2M; Nurse Gets 9 Years

Christopher Sheerer, DO, a pediatric cardiac anesthesiology fellow at Boston Children’s Hospital, who was accused of possessing and distributing child sexual abuse material, was fired

July 26, 2024

Male diabetics more likely to have lower limb amputation

New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October)

August 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.